Pinduoduo Pre-market Stock Up After Q3 Earnings Surge

Pinduoduo Inc. (PDD), a Chinese firm focused on traditional agriculture industry, on Monday reported a surge in earnings for the third quarter, driven by an increase in revenue.

For the three-months to September 30, the company registered a net income of RMB10.589 billion or RMB1.84 per share, compared with RMB1.639 billion or RMB 0.29 per share in the same quarter of 2021.

Earnings per ADS stood at RMB7.34, versus RMB1.15 per ADS of previous fiscal.

Excluding items, income was at RMB12.447 billion or RMB2.15 per share, higher than RMB3.150 billion or RMB0.55 per share, a year ago.

Adjusted earnings per ADS were at RMB8.62, compared with RMB2.18 per ADS of last year quarter.

Operating profit moved up 388 percent to RMB10.436 billion or $1.47 billion, higher than last year's RMB2.139 billion.

Pinduoduo generated revenue of RMB35.504 billion or $5 billion, 65 percent higher than RMB21.505 billion in the same quarter of 2021.

PDD is trading up by 15.89 percent at $76.25 per share in pre-market on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT